B. Van Hoef

3.2k total citations
70 papers, 2.7k citations indexed

About

B. Van Hoef is a scholar working on Cancer Research, Hematology and Biotechnology. According to data from OpenAlex, B. Van Hoef has authored 70 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Cancer Research, 34 papers in Hematology and 22 papers in Biotechnology. Recurrent topics in B. Van Hoef's work include Protease and Inhibitor Mechanisms (56 papers), Blood Coagulation and Thrombosis Mechanisms (31 papers) and Enzyme Production and Characterization (22 papers). B. Van Hoef is often cited by papers focused on Protease and Inhibitor Mechanisms (56 papers), Blood Coagulation and Thrombosis Mechanisms (31 papers) and Enzyme Production and Characterization (22 papers). B. Van Hoef collaborates with scholars based in Belgium, France and United Kingdom. B. Van Hoef's co-authors include D Collen, H.R. Lijnen, H.R. Lijnen, Désiré Collen, F De Cock, Désiré Collen, Erik Maquoi, Liesbeth Frederix, H. Roger Lijnen and L Nelles and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Journal of Molecular Biology.

In The Last Decade

B. Van Hoef

70 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Van Hoef Belgium 34 1.5k 915 851 538 509 70 2.7k
Cynthia C. Daugherty United States 20 803 0.5× 837 0.9× 772 0.9× 343 0.6× 586 1.2× 41 2.8k
Raymond R. Schleef United States 29 1.2k 0.8× 1.3k 1.4× 620 0.7× 209 0.4× 606 1.2× 57 2.7k
Thomas J. Podor Canada 29 629 0.4× 681 0.7× 747 0.9× 232 0.4× 331 0.7× 49 2.6k
Yuji Yamanishi Japan 21 1.1k 0.7× 211 0.2× 1.1k 1.3× 318 0.6× 245 0.5× 40 3.2k
F De Cock Belgium 27 1.1k 0.7× 1.1k 1.2× 567 0.7× 182 0.3× 719 1.4× 55 2.3k
Khalil Bdeir United States 34 801 0.5× 668 0.7× 860 1.0× 361 0.7× 362 0.7× 76 2.7k
Junko H. Ohyashiki Japan 32 1.7k 1.1× 1.3k 1.4× 3.3k 3.8× 225 0.4× 196 0.4× 183 5.1k
Masaaki Moroi Japan 37 683 0.5× 3.1k 3.4× 662 0.8× 114 0.2× 1.3k 2.5× 92 4.5k
J D Griffin United States 32 347 0.2× 945 1.0× 1.3k 1.5× 185 0.3× 154 0.3× 47 3.7k
Masaki Inoue Japan 33 368 0.2× 463 0.5× 1.1k 1.3× 358 0.7× 153 0.3× 93 3.2k

Countries citing papers authored by B. Van Hoef

Since Specialization
Citations

This map shows the geographic impact of B. Van Hoef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Van Hoef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Van Hoef more than expected).

Fields of papers citing papers by B. Van Hoef

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Van Hoef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Van Hoef. The network helps show where B. Van Hoef may publish in the future.

Co-authorship network of co-authors of B. Van Hoef

This figure shows the co-authorship network connecting the top 25 collaborators of B. Van Hoef. A scholar is included among the top collaborators of B. Van Hoef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Van Hoef. B. Van Hoef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lijnen, H.R., Liesbeth Frederix, B. Van Hoef, & Mieke Dewerchin. (2008). Deficiency of vascular endothelial growth factor-D does not affect murine adipose tissue development. Biochemical and Biophysical Research Communications. 378(2). 255–258. 10 indexed citations
2.
Nagai, N., B. Van Hoef, & H.R. Lijnen. (2007). Plasminogen activator inhibitor‐1 contributes to the deleterious effect of obesity on the outcome of thrombotic ischemic stroke in mice. Journal of Thrombosis and Haemostasis. 5(8). 1726–1731. 43 indexed citations
3.
Lijnen, H.R., Marie‐Christine Alessi, B. Van Hoef, D Collen, & I. Juhan‐Vague. (2005). On the role of plasminogen activator inhibitor‐1 in adipose tissue development and insulin resistance in mice. Journal of Thrombosis and Haemostasis. 3(6). 1174–1179. 56 indexed citations
4.
Nagai, N., Yasuo Suzuki, B. Van Hoef, H.R. Lijnen, & D Collen. (2005). Effects of plasminogen activator inhibitor‐1 on ischemic brain injury in permanent and thrombotic middle cerebral artery occlusion models in mice. Journal of Thrombosis and Haemostasis. 3(7). 1379–1384. 49 indexed citations
5.
Lijnen, H.R., B. Van Hoef, Kimberly Umans, & D Collen. (2004). Neointima formation and thrombosis after vascular injury in transgenic mice overexpressing plasminogen activator inhibitor‐1 (PAI‐1). Journal of Thrombosis and Haemostasis. 2(1). 16–22. 20 indexed citations
6.
Nagai, N., et al.. (2003). Recombinant human microplasmin: production and potential therapeutic properties. Journal of Thrombosis and Haemostasis. 1(2). 307–313. 70 indexed citations
7.
Lijnen, H.R., et al.. (2000). Inactivation of Plasminogen Activator Inhibitor-1 by Specific Proteolysis with Stromelysin-1 (MMP-3). Journal of Biological Chemistry. 275(48). 37645–37650. 50 indexed citations
8.
Lijnen, H.R., B. Van Hoef, Mieke Dewerchin, & D Collen. (2000). α 2 -Antiplasmin Gene Deficiency in Mice Does Not Affect Neointima Formation After Vascular Injury. Arteriosclerosis Thrombosis and Vascular Biology. 20(6). 1488–1492. 16 indexed citations
9.
Jespers, Laurent, H.R. Lijnen, Sophie Vanwetswinkel, et al.. (1999). Guiding a docking mode by phage display: selection of correlated mutations at the staphylokinase-plasmin interface. Journal of Molecular Biology. 290(2). 471–479. 18 indexed citations
10.
Ugwu, Francisca, B. Van Hoef, A. Bini, Désiré Collen, & H.R. Lijnen. (1998). Proteolytic Cleavage of Urokinase-Type Plasminogen Activator by Stromelysin-1 (MMP-3). Biochemistry. 37(20). 7231–7236. 63 indexed citations
11.
Lijnen, H.R., B. Van Hoef, & D Collen. (1996). Characterization of the murine plasminogen/urokinase‐type plasminogen‐activator system. European Journal of Biochemistry. 241(3). 840–848. 29 indexed citations
12.
Lijnen, H.R., Stephan Wnendt, Johannes Schneider, et al.. (1995). Functional Properties of a Recombinant Chimeric Protein with Combined Thrombin Inhibitory and Plasminogen‐Activating Potential. European Journal of Biochemistry. 234(1). 350–357. 15 indexed citations
13.
Lijnen, H.R., F De Cock, B. Van Hoef, Bernhard Schlott, & D Collen. (1994). Characterization of the Interaction Between Plasminogen and Staphylokinase. European Journal of Biochemistry. 224(1). 143–149. 54 indexed citations
14.
Lijnen, H.R., et al.. (1994). Characterization of the Murine Plasma Fibrinolytic System. European Journal of Biochemistry. 224(3). 863–871. 88 indexed citations
15.
Collen, D, B. Van Hoef, Bernhard Schlott, et al.. (1993). Mechanisms of activation of mammalian plasma fibrinolytic systems with streptokinase and with recombinant staphylokinase. European Journal of Biochemistry. 216(1). 307–314. 46 indexed citations
16.
Lijnen, H.R., B. Van Hoef, & D Collen. (1993). Interaction of staphylokinase with different molecular forms of plasminogen. European Journal of Biochemistry. 211(1-2). 91–97. 25 indexed citations
17.
Lijnen, H.R., B. Van Hoef, Osamu Matsuo, & D Collen. (1992). On the molecular interactions between plasminogen-staphylokinase, α2-antiplasmin-formula> and fibrin. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1118(2). 144–148. 41 indexed citations
18.
Lijnen, H.R., B. Van Hoef, L Nelles, William E. Holmes, & Désiré Collen. (1988). Enzymatic properties of single‐chain and two‐chain forms of a Lys158→ Glu158 mutant of urokinase–type plasminogen activator. European Journal of Biochemistry. 172(1). 185–188. 15 indexed citations
19.
Lijnen, H.R., B. Van Hoef, & Désiré Collen. (1987). Activation with plasmin of two-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin. European Journal of Biochemistry. 169(2). 359–364. 44 indexed citations
20.
Lijnen, H.R., B. Van Hoef, & Désiré Collen. (1987). Differential reactivity of Glu-Gly-Arg-CH2Cl, a synthetic urokinase inhibitor, with single-chain and two-chain forms of urokinase-type plasminogen activator. European Journal of Biochemistry. 162(2). 351–356. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cynthia C. Daugherty Breakdown of academic impact, for papers by Raymond R. Schleef Breakdown of academic impact, for papers by Thomas J. Podor Breakdown of academic impact, for papers by Yuji Yamanishi Breakdown of academic impact, for papers by F De Cock Breakdown of academic impact, for papers by Khalil Bdeir Breakdown of academic impact, for papers by Junko H. Ohyashiki Breakdown of academic impact, for papers by Masaaki Moroi Breakdown of academic impact, for papers by J D Griffin Breakdown of academic impact, for papers by Masaki Inoue
Rankless by CCL
2026